Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Merck’s keytruda cuts death risk in oesophageal cancer

Keytruda is an anti-PD-1, humanised monoclonal antibody for the treatment of cancer. Credit: Merck Sharp & Dohme Corp.

  • Keytruda KEYNOTE-181 trial data

Go Top